NCT00003372View on ClinicalTrials.gov

Topotecan in Treating Patients With Recurrent Brain Tumors

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

December 8, 1997

Primary Completion Date

October 5, 2000

Study Completion Date

December 21, 2009

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

topotecan hydrochloride

Trial Locations (11)

T2N 4N2

Tom Baker Cancer Center - Calgary, Calgary

T6G 1Z2

Cross Cancer Institute, Edmonton

V5Z 4E6

BC Cancer Agency, Vancouver

R3E 0V9

CancerCare Manitoba, Winnipeg

K7L 5P9

Kingston Regional Cancer Centre, Kingston

N6A 4L6

Cancer Care Ontario-London Regional Cancer Centre, London

K1Y 4K7

Ottawa Regional Cancer Centre - Civic Campus, Ottawa

M4N 3M5

Toronto Sunnybrook Regional Cancer Centre, Toronto

M5G 2M9

Princess Margaret Hospital, Toronto

H2L-4M1

Centre Hospitalier de l'Universite de Montreal, Montreal

H2W 1S6

McGill University Department of Oncology, Montreal

Sponsors
All Listed Sponsors
lead

NCIC Clinical Trials Group

NETWORK

NCT00003372 - Topotecan in Treating Patients With Recurrent Brain Tumors | Biotech Hunter | Biotech Hunter